Oral ribupatide (KAI-9531-T) An investigational once-daily oral tablet formulation of the GLP-1/GIP receptor dual agonist ribupatide being developed for obesity.
Visit productCosigns Received
Be the first Cosign
Put your name behind Oral ribupatide (KAI-9531-T).
Add it to your Products I use list and share why you use it.